How Precision Medicine Helped Breast Cancer Treatment
Advances in precision medicine have improved breast cancer treatment, according to a new study.
A New Rx for Cancer of the Soft Tissues
The US Food and Drug Administration (FDA) has approved Lartruvo (olaratumab) to treat soft tissue sarcoma (STS).
Tecentriq Gets a New Job
The US Food and Drug Administration has approved Tecentriq (atezolizumab) to treat advanced lung cancer.
A Possible Risk of Androgen Deprivation Therapy
Men with prostate cancer who take androgen-lowering medication may have a raised risk of dementia, a new study found.
Boosting Leukemia Survival
Umbilical cord blood transplants may lead to high survival in patients with leukemia who are at high risk for relapse post-transplant, a new study found.
Ovarian Cancer Screening: A Warning
The US Food and Drug Administration (FDA) has issued a warning about tests being marketed to screen for ovarian cancer.
More Cancer Types Linked to Obesity
A new study has linked obesity to eight more types of cancer.
The Longer You Weight
The longer women are overweight or obese as adults, the more likely they may be to get cancer, a new study found.
More Exercise, Less Disease
Many past studies have shown that physical activity provides health benefits, but exactly how much physical activity provides the most benefit?
In Vitro and Breast Cancer Risk
In vitro fertilization (IVF) treatments were not tied to an increased risk of breast cancer, a new study found.